Late-onset hypogonadism (LOH) is a complex and highly debatable syndrome in ageing men, which is characterised by reduced testosterone levels associated with classical symptoms of androgen deficiency. This article discusses the complex issues surrounding its management related to patient-centric thresholds and therapeutic targets. It specifically highlights the need to consider symptoms as the starting point, the key milestones in the management and the target of treatment, while ensuring safety at all times. The diagnosis of LOH requires a high index of suspicion and early identification of symptoms followed by appropriate investigations. The threshold for initiation of treatment has to be person centric and requires individualised decisio...
INTRODUCTION: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, char...
Male hypogonadism (HG) can be defined according to its etiology as primary (pHG) when caused by any ...
Purpose: Late-onset hypogonadism (LOH) in aging males is a clinical and biochemical syndrome charact...
Introduction: As the world population grows older late-onset hypogonadism is becoming a major health...
Late-onset hypogonadism (LOH) is a condition that affects an estimated 10% of men aged > 50 years an...
The use of testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) is increasing ev...
Late-onset hypogonadism (LOH) is a syndrome characterized by clinical and biochemical evidence of lo...
The study investigates late-onset hypogonadism (LOH), its influence on male joint system, build, car...
Late-onset hypogonadism (LOH) is an emerging pathophysiological entity. Not everybody is familiar wi...
Late-onset hypogonadism (LOH) is a syndromic condition that has a well-recognized association with s...
The term ‘male menopause ’ was first used in 1944 to describe various complaints of ageing men which...
The article presents a review of the literature, which indicate the current understanding of the cli...
Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism (LOH) in men w...
AIM Although "late onset hypogonadism", a condition that includes low testosterone and symptoms, ...
Male Hypogonadism is the condition diagnosed in men with signs and symptoms of testosterone deficien...
INTRODUCTION: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, char...
Male hypogonadism (HG) can be defined according to its etiology as primary (pHG) when caused by any ...
Purpose: Late-onset hypogonadism (LOH) in aging males is a clinical and biochemical syndrome charact...
Introduction: As the world population grows older late-onset hypogonadism is becoming a major health...
Late-onset hypogonadism (LOH) is a condition that affects an estimated 10% of men aged > 50 years an...
The use of testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) is increasing ev...
Late-onset hypogonadism (LOH) is a syndrome characterized by clinical and biochemical evidence of lo...
The study investigates late-onset hypogonadism (LOH), its influence on male joint system, build, car...
Late-onset hypogonadism (LOH) is an emerging pathophysiological entity. Not everybody is familiar wi...
Late-onset hypogonadism (LOH) is a syndromic condition that has a well-recognized association with s...
The term ‘male menopause ’ was first used in 1944 to describe various complaints of ageing men which...
The article presents a review of the literature, which indicate the current understanding of the cli...
Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism (LOH) in men w...
AIM Although "late onset hypogonadism", a condition that includes low testosterone and symptoms, ...
Male Hypogonadism is the condition diagnosed in men with signs and symptoms of testosterone deficien...
INTRODUCTION: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, char...
Male hypogonadism (HG) can be defined according to its etiology as primary (pHG) when caused by any ...
Purpose: Late-onset hypogonadism (LOH) in aging males is a clinical and biochemical syndrome charact...